Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Drug Discovery Today
|
July 7, 2009
Histone acetyl transferases as emerging drug targets
Frank J Dekker, Hidde J Haisma
Molecular Pharmaceutics
|
October 29, 2010
Pharmacological interventions for improving adenovirus usage in gene therapy
Hidde J Haisma, Anna Rita Bellu
Cancers
|
April 3, 2021
Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy
Olivia A Diaz Arguello, Hidde J Haisma
Drug Discovery Today
|
March 9, 2019
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Bin Liu, Ali Saber, Hidde J Haisma
European Journal of Medicinal Chemistry
|
August 18, 2009
Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase
Massimo Ghizzoni, Hidde J Haisma, Frank J Dekker
Nucleic Acids Research
|
October 25, 2003
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities
Taco G Uil, Hidde J Haisma, Marianne G Rots
Drug Discovery Today
|
November 25, 2021
Modulating CRISPR/Cas9 genome-editing activity by small molecules
Siwei Chen, Deng Chen, Bin Liu, et al.
Journal of Molecular Biology
|
October 29, 2005
Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command
Willemijn M Gommans, Hidde J Haisma, Marianne G Rots
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences
|
January 23, 2019
CRISPR/Cas9 for overcoming drug resistance in solid tumors
Ali Saber, Bin Liu, Pirooz Ebrahimi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 17, 2010
Endosomal escape pathways for delivery of biologicals
Amir K Varkouhi, Marije Scholte, Gert Storm, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Drug Discovery Today
|
July 7, 2009
Histone acetyl transferases as emerging drug targets
Frank J Dekker, Hidde J Haisma
Molecular Pharmaceutics
|
October 29, 2010
Pharmacological interventions for improving adenovirus usage in gene therapy
Hidde J Haisma, Anna Rita Bellu
Cancers
|
April 3, 2021
Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy
Olivia A Diaz Arguello, Hidde J Haisma
Drug Discovery Today
|
March 9, 2019
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Bin Liu, Ali Saber, Hidde J Haisma
European Journal of Medicinal Chemistry
|
August 18, 2009
Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase
Massimo Ghizzoni, Hidde J Haisma, Frank J Dekker
Nucleic Acids Research
|
October 25, 2003
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities
Taco G Uil, Hidde J Haisma, Marianne G Rots
Drug Discovery Today
|
November 25, 2021
Modulating CRISPR/Cas9 genome-editing activity by small molecules
Siwei Chen, Deng Chen, Bin Liu, et al.
Journal of Molecular Biology
|
October 29, 2005
Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command
Willemijn M Gommans, Hidde J Haisma, Marianne G Rots
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences
|
January 23, 2019
CRISPR/Cas9 for overcoming drug resistance in solid tumors
Ali Saber, Bin Liu, Pirooz Ebrahimi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 17, 2010
Endosomal escape pathways for delivery of biologicals
Amir K Varkouhi, Marije Scholte, Gert Storm, et al.
Page
of 8